Bionano Genomics
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 344
- Market Cap
- -
- Introduction
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Clinical Trials
1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort
- Conditions
- Developmental DisabilityFragile X SyndromeIntellectual DisabilityFacioscapulohumeral Muscular Dystrophy 1Autism Spectrum DisorderCongenital Anomaly
- First Posted Date
- 2022-03-25
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Bionano Genomics
- Target Recruit Count
- 1000
- Registration Number
- NCT05295277
- Locations
- 🇺🇸
Praxis Genomics, Atlanta, Georgia, United States
🇺🇸Augusta University Research Institute, Augusta, Georgia, United States
🇺🇸University of Iowa Hospitals & Clinics, Molecular Pathology, Iowa City, Iowa, United States